Michael C. Quirk is of Sage Therapeutics, Inc.. Currently has a direct ownership of 0 shares of SAGE, which is worth approximately $0. The most recent transaction as insider was on Jul 31, 2025, when has been sold 32,961 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
100.0% 3M change
n/a 12M change
Total Value Held $0

Michael C. Quirk Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jul 31 2025
SELL
Sale (or disposition) back to the issuer
-
32,961 Reduced 100.0%
0 Common Stock
Jun 24 2025
SELL
Payment of exercise price or tax liability
$1,041 $9.22 p/Share
113 Reduced 0.37%
30,461 Common Stock
Apr 01 2025
BUY
Grant, award, or other acquisition
-
2,000 Added 6.43%
29,108 Common Stock
MCQ

Michael C. Quirk

Cambridge, MA

Track Institutional and Insider Activities on SAGE

Follow Sage Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SAGE shares.

Notify only if

Insider Trading

Get notified when an Sage Therapeutics, Inc. insider buys or sells SAGE shares.

Notify only if

News

Receive news related to Sage Therapeutics, Inc.

Track Activities on SAGE